Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | RHOA | P61586 | 1/20 | 0.44 |
| ▸ | LIG1 | P18858 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6551356 | 0.88 | CYP3A4 (0.77) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL16371573 | 0.86 | CYP3A4 (1.00) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL27474785 | 0.86 | CYP3A4 (1.00) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL15174 | 0.86 | CYP3A4 (1.00) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL29362146 | 0.86 | CYP3A4 (1.00) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL1696561 | 0.85 | CYP3A4 (0.83) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| Formic Acid SCHEMBL28100783 | 0.84 | CYP3A4 (0.89) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL11394446 | 0.84 | CYP3A4 (0.96) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| SCHEMBL11394440 | 0.84 | CYP3A4 (0.96) | CYP3A4TSHRALDH1A1HSD17B10RHOA | |
| Ethylene SCHEMBL11883084 | 0.84 | CYP3A4 (0.96) | CYP3A4TSHRALDH1A1HSD17B10RHOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5201920-A | — | — | None | — | — | JP | disclosed |
| US-10042291-B2 | Intermediate transfer member, image forming apparatus and image forming method | Konica Minolta, Inc. (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20170357191-A1 | INTERMEDIATE TRANSFER MEMBER, IMAGE FORMING APPARATUS AND IMAGE FORMING METHOD | Konica Minolta, Inc. (JP) | 2017-12-14 | — | — | US | disclosed |
| US-20150378282-A1 | TRANSFER MEMBER AND IMAGE FORMING APPARATUS | Konica Minolta, Inc. (JP) | 2015-12-31 | — | — | US | disclosed |
| US-9173395-B2 | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-11-03 | — | — | US | disclosed |
| US-20140302987-A1 | USE OF SUBSTITUTED ISOQUINOLINONES, ISOQUINOLINDIONES, ISOQUINOLINTRIONES AND DIHYDROISOQUINOLINONES OR IN EACH CASE SALTS THEREOF AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-10-09 | — | — | US | disclosed |
| EP-0795548-B1 | QUINAZOLINE DERIVATIVES AND USE THEREOF | SUNTORY LTD (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-5814631-A | CHYMASE INHIBITOR, CARDIVASCULAR | SUNTORY LIMITED (JP) | 1998-09-29 | — | — | US | disclosed |
| EP-0795548-A1 | QUINAZOLINE DERIVATIVES AND USE THEREOF | SUNTORY LIMITED (JP) | 1997-09-17 | — | — | EP | disclosed |
| EP-0581024-B1 | Polyester compounds and organic gelling agents comprising same | NEW JAPAN CHEM CO LTD (JP) | 1997-04-02 | — | — | EP | disclosed |
| US-5356566-A | Polyester compounds and organic gelling agents comprising same | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| EP-0581024-A1 | Polyester compounds and organic gelling agents comprising same | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1994-02-02 | — | — | EP | disclosed |
| JP-H05201920-A | PRODUCTION OF FORMYLBENZOIC ACID | TEIJIN LTD | 1993-08-10 | — | — | JP | disclosed |
| US-4133801-A | Process for the preparation of polyesters | TEIJIN LIMITED (JP) | 1979-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140302987-A1 | USE OF SUBSTITUTED ISOQUINOLINONES, ISOQUINOLINDIONES, ISOQUINOLINTRIONES AND DIHYDROISOQUINOLINONES OR IN EACH CASE SALTS THEREOF AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS | NQO1, NFE2, NDUFS1 | CYP3A4 391/4885TSHR 4501/4885ALDH1A1 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.